Intended and unintended consequences of China's zero markup drug policy

Health Affairs

Volumn 34, Issue 8, 2015, Pages 1391-1398

  Yi, Hongmei ^a   Miller, Grant ^b,c   Zhang, Linxiu ^a   Li, Shaoping ^a   Rozelle, Scott ^c  

^a INSTITUTE OF GEOGRAPHIC SCIENCES AND NATURAL RESOURCES RESEARCH   (China)

^b Center for International Development   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHINA; DRUG MARKETING; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CENTER; HEALTH SERVICE; HOSPITAL CARE; PROFIT; ZERO MARKUP DRUG POLICY; COST CONTROL; DRUG COST; ECONOMICS; PRESCRIPTION; PROCEDURES; PUBLIC HEALTH; STANDARDS; TRENDS;

ESSENTIAL DRUG; PRESCRIPTION DRUG;

CHINA; COST CONTROL; DRUG COSTS; DRUG PRESCRIPTIONS; DRUGS, ESSENTIAL; HEALTH CARE REFORM; HEALTH POLICY; NATIONAL HEALTH PROGRAMS; PRESCRIPTION DRUGS;

EID: 84938691068     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2014.1114     Document Type: Article

References (35)

1. Wagstaff A, Lindelow M, Wang S, Zhang S. Reforming China's rural health system [Internet]. Washington (DC): World Bank; 2009 [cited 2015 Jun 16]. Available from: http:// siteresources.worldbank.org/CHINAEXTN/Resources/318949-1248160372290/rural_health_full_ report_en.pdf
2. Yip W, Mahal A. The health care systems of China and India: performance and future challenges. Health Aff (Millwood). 2008;27(4):921-32.
3. Yip W, Powell-Jackson T, Chen W, Hu M, Fe E, Hu M, et al. Capitation combined with pay-for-performance improves antibiotic prescribing practices in rural China. Health Aff (Millwood). 2014;33(3):502-10.
4. Yip W, HsiaoWC. The Chinese health system at a crossroads. Health Aff (Millwood). 2008;27(2):460-8.
5. Yip WC, Hsiao W, Meng Q, Chen W, Sun X. Realignment of incentives for health-care providers in China. Lancet. 2010;375(9720):1120-30.
6. Hsiao WC. The Chinese health care system: lessons for other nations. Soc Sci Med. 1995;41(8):1047-55.
7. Blumenthal D, Hsiao W. Privatization and its discontents-the evolving Chinese health care system. N Engl J Med. 2005;353(11):1165-70.
8. Yip W, Eggleston K. Addressing government and market failures with payment incentives: hospital reimbursement reform in Hainan, China. Soc Sci Med. 2004;58(2):267-77.
9. Dong H, Bogg L, Rehnberg C, Diwan V. Drug policy in China: pharmaceutical distribution in rural areas. Soc Sci Med. 1999;48(6):777-86.
10. Sun Q, Santoro MA, Meng Q, Liu C, Eggleston K. Pharmaceutical policy in China. Health Aff (Millwood). 2008;27(4):1042-50.
11. Gao J, Wang M, Ji L, Bai X. Analysis of the profit rate and profit of drugs in township hospitals under the background of the drug zero slip policy. Chinese Health Economics. 2011;30(9):19-21. Chinese.
12. Jiang Q, Yu BN, Ying G, Liao J, Gan H, Blanchard J, et al. Outpatient prescription practices in rural township health centers in Sichuan Province, China. BMC Health Serv Res. 2012;12:324.
13. Currie J, Lin W, Meng J. Addressing antibiotic abuse in China: an experimental audit study. J Dev Econ. 2014;110:39-51.
14. Babiarz KS, Miller G, Yi H, Zhang L, Rozelle S. New evidence on the impact of China's New Rural Cooperative Medical Scheme and its implications for rural primary healthcare:multivariate difference-in-difference analysis. BMJ. 2010;341:c5617.
15. Sun X, Jackson S, Carmichael GA, Sleigh AC. Prescribing behaviour of village doctors under China's New Cooperative Medical Scheme. Soc Sci Med. 2009;68(10):1775.
16. Central Committee of the Communist Party of China and State Council of China. Opinions of the CPC Central Committee and the State Council on deepening the reform of the medical and health care system [Internet]. Beijing: Central Committee of the Communist Party of China, State Council of China; 2009 Apr 6 [cited 2015 Jun 24]. Available from:http://www.gov.cn/jrzg/2009-04/06/content_1278721.htm. Chinese.
17. Yip WC, Hsiao WC, Chen W, Hu S, Ma J, Maynard A. Early appraisal of China's huge and complex healthcare reforms. Lancet. 2012; 379(9818):833-42.
18. State Council of China. Implementation plan for the recent priorities of the medical and health care system reform (2009-11) [Internet]. Beijing: State Council of China; 2009 Apr 7 [cited 2015 Jun 24]. Available from: http://www.gov.cn/zwgk/2009-04/07/content_1279256.htm. Chinese.
19. Xiao Y, Zhao K, Bishai DM, Peters DH. Essential drugs policy in three rural counties in China: what does a complexity lens add? Soc Sci Med. 2013;93:220-8.
20. Li Y, Ying C, Sufang G, Brant P, Bin L, Hipgrave D. Evaluation, in three provinces, of the introduction and impact of China's National Essential Medicines Scheme. Bull World Health Organ. 2013;91(3):184-94.
21. Yang L, Liu C, Ferrier JA, Zhou W, Zhang X. The impact of the National Essential Medicines Policy on prescribing behaviours in primary care facilities in Hubei Province of China. Health Policy Plan. 2013;28(7):750-60.
22. Ministry of Health of China. National Essential Drug System was established, and patients' expenses on drugs were reduced [Internet]. Beijing: The Ministry; 2011 Oct 12 [cited 2015 Jun 24]. Available from:http://www.moh.gov.cn/mohywzc/ s7652/201110/53137.shtml. Chinese.
23. Chen Y, Bai B, Dai T. Effect on implementing essential medicine system at primary health care institutions in Anhui Province. Chinese Journal of Health Policy. 2013;6(4):31-5. Chinese.
24. Song Y, Bian Y, Petzold M, Li L, YIn A. Effects of the National Essential Medicine System in reducing drug prices: an empirical study in four Chinese provinces. J Pharm Policy Pract. 2014;7(1):12.
25. Hu S. Essential medicine policy in China: pros and cons. J Med Econ. 2013;16(2):289-94.
26. Li K, Sun Q, ZUO G, Yang H, Meng Q. Study on the impact of essential medicine system on the patient visits and cost in township hospital: based on the evaluation method of difference in difference. Chinese Health Economics. 2012;31(4):62-4. Chinese.
27. Chen Y, Jin GZ. Does health insurance coverage lead to better health and educational outcomes? Evidence from rural China. J Health Econ. 2012;31(1):1-14.
28. Zhou Z, Su Y, Campbell B, Zhou Z, Gao J, Yu Q, et al. The financial impact of the "zero-markup policy for essential drugs" on patients in county hospitals in western rural China. PLoS One. 2015;10(3):e0121630.
29. Zhou Z, Su Y, Campbell B, Zhou Z, Gao J, Yu Q, et al. The impact of China's Zero-Markup Drug Policy on county hospital revenue and government subsidy levels. Journal of Asian Public Policy. 2015;8(1):102-16.
30. Fang Y,Wagner AK,Yang S, Jiang M, Zhang F, Ross-Degnan D. Access to affordable medicines after health reform: evidence from two crosssectional surveys in Shaanxi Province, western China. Lancet Glob Health. 2013;1(4):e227-37.
31. Babiarz KS, Miller G, Yi H, Zhang L, Rozelle S. China's New Cooperative Medical Scheme improved finances of township health centers but not the number of patients served. Health Aff (Millwood). 2012;31(5):1065-74.
32. National Audit Office of China. Results of auditing the New Cooperative Medical Scheme funding in 45 counties [Internet]. Beijing: National Audit Office of China; 2011 Nov 26 [cited 2015 Jun 24]. Available from: http://www.audit.gov.cn/ n1992130/n1992150/n1992500/2649036.html. Chinese.
33. Office of State Council of China. Suggestions about consolidating and improving National Essential Drug Policy and new operation mechanism of primary health facilities [Internet]. Beijing: Office of State Council of China; 2013 Feb 13 [cited 2015 Jun 24]. Available from: http:// www.moh.gov.cn/mohzcfgs/s9660/201302/ec44be6a90c945459820 f54a4ad9e6ef.shtml. Chinese.
34. Das J, Hammer J. Quality of primary care in low-income countries: facts and economics. Annu Rev Econom. 2014;6:525-53.
35. Miller G, Babiarz KS. Pay-forperformance incentives in low- and middle-income country health programs [Internet]. Cambridge (MA):National Bureau of Economic Research; 2013 Apr [cited 2015 Jun 17]. (NBER Working Paper No. 18932). Available from: http://www.nber .org/papers/w18932.pdf